|
US4647447A
(en)
|
1981-07-24 |
1987-03-03 |
Schering Aktiengesellschaft |
Diagnostic media
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
EP0563475B1
(en)
|
1992-03-25 |
2000-05-31 |
Immunogen Inc |
Cell binding agent conjugates of derivatives of CC-1065
|
|
US5395619A
(en)
|
1993-03-03 |
1995-03-07 |
Liposome Technology, Inc. |
Lipid-polymer conjugates and liposomes
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
US5637684A
(en)
|
1994-02-23 |
1997-06-10 |
Isis Pharmaceuticals, Inc. |
Phosphoramidate and phosphorothioamidate oligomeric compounds
|
|
ES2285707T3
(es)
|
1994-10-21 |
2007-11-16 |
Nps Pharmaceuticals, Inc. |
Compuestos activos frente al receptor de calcio.
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
US5817856A
(en)
|
1995-12-11 |
1998-10-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Radiation-protective phospholipid and method
|
|
US5830600A
(en)
|
1996-05-24 |
1998-11-03 |
Sri International |
Nonflammable/self-extinguishing electrolytes for batteries
|
|
JPH10175987A
(ja)
|
1996-12-13 |
1998-06-30 |
Nof Corp |
重合性基含有有機リン酸エステル化合物およびその製造方法
|
|
US6180095B1
(en)
|
1997-12-17 |
2001-01-30 |
Enzon, Inc. |
Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
|
|
US5922897A
(en)
|
1998-05-29 |
1999-07-13 |
Xerox Corporation |
Surfactant processes
|
|
US20030165849A1
(en)
|
2000-11-28 |
2003-09-04 |
Biliang Zhang |
Methods and reagents for introducing a sulfhydryl group into the 5'-terminus of RNA
|
|
US6320041B1
(en)
|
2001-04-13 |
2001-11-20 |
Trilink Biotechnologies, Inc. |
Pre-activated carbonyl linkers for the modification of oligonucleotides
|
|
US6743905B2
(en)
|
2001-04-16 |
2004-06-01 |
Applera Corporation |
Mobility-modified nucleobase polymers and methods of using same
|
|
JP2005503425A
(ja)
|
2001-05-24 |
2005-02-03 |
アレックザ モレキュラー デリヴァリー コーポレイション |
所定の吸入ルートによる薬剤エステルの送出
|
|
US20100240730A1
(en)
|
2002-02-20 |
2010-09-23 |
Merck Sharp And Dohme Corp. |
RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
|
|
US20040062748A1
(en)
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
|
AU2004212941B2
(en)
|
2003-02-14 |
2011-05-26 |
Quanta Biodesign, Ltd |
The selective and specific preparation of discrete PEG compounds
|
|
EP2478912B1
(en)
|
2003-11-06 |
2016-08-31 |
Seattle Genetics, Inc. |
Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
|
|
WO2005077966A1
(en)
|
2004-02-10 |
2005-08-25 |
Isis Pharmaceuticals, Inc. |
Substituted pixyl protecting groups for oligonucleotide synthesis
|
|
CA2940803A1
(en)
|
2004-03-23 |
2005-10-27 |
Ascendis Pharma Gmbh |
Prodrug linker
|
|
EP1758575A1
(en)
*
|
2004-06-11 |
2007-03-07 |
Novo Nordisk A/S |
Counteracting drug-induced obesity using glp-1 agonists
|
|
US20060063147A1
(en)
|
2004-09-21 |
2006-03-23 |
Chernov Boris K |
Omega-amino-PEG-phosphoramidites and conjugates thereof
|
|
TW200612993A
(en)
|
2004-10-08 |
2006-05-01 |
Alza Corp |
Lipopolymer conjugates
|
|
AU2006304856A1
(en)
|
2005-10-21 |
2007-04-26 |
Synageva Biopharma Corp. |
Glycolated and glycosylated poultry derived therapeutic proteins
|
|
WO2007055789A2
(en)
|
2005-10-31 |
2007-05-18 |
Neose Technologies, Inc. |
Expression of soluble therapeutic proteins
|
|
AU2006316903B8
(en)
|
2005-11-23 |
2010-10-14 |
F. Hoffmann-La Roche Ag |
Polynucleotide labelling reagent
|
|
EP2364735A3
(en)
|
2005-12-16 |
2012-04-11 |
Nektar Therapeutics |
Branched PEG conjugates of GLP-1
|
|
JP5140824B2
(ja)
|
2006-04-19 |
2013-02-13 |
国立大学法人 東京大学 |
リゾホスファチジルスレオニンおよびその誘導体
|
|
US7985783B2
(en)
|
2006-09-21 |
2011-07-26 |
The Regents Of The University Of California |
Aldehyde tags, uses thereof in site-specific protein modification
|
|
WO2008067127A2
(en)
|
2006-11-09 |
2008-06-05 |
Alcon Research, Ltd. |
Water insoluble polymer matrix for drug delivery
|
|
US20130195888A1
(en)
|
2007-11-30 |
2013-08-01 |
Abbvie |
Ultrafiltration and diafiltration formulation methods for protein processing
|
|
US8883146B2
(en)
|
2007-11-30 |
2014-11-11 |
Abbvie Inc. |
Protein formulations and methods of making same
|
|
AU2009209565B2
(en)
|
2008-02-01 |
2013-09-19 |
Ascendis Pharma As |
Prodrug comprising a self-cleavable linker
|
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
|
US8883211B2
(en)
|
2008-07-10 |
2014-11-11 |
Serina Therapeutics, Inc. |
Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds
|
|
EP2334335A1
(en)
|
2008-09-19 |
2011-06-22 |
Nektar Therapeutics |
Polymer conjugates of cd-np peptides
|
|
PT2432489T
(pt)
|
2009-05-20 |
2016-12-07 |
Biomarin Pharm Inc |
Variantes do péptido natriurético de tipo c
|
|
WO2011012722A1
(en)
|
2009-07-31 |
2011-02-03 |
Ascendis Pharma As |
Prodrugs containing an aromatic amine connected by an amido bond to a linker
|
|
US9062094B2
(en)
|
2010-01-22 |
2015-06-23 |
Ascendis Pharma As |
Dipeptide-based prodrug linkers for aliphatic amine-containing drugs
|
|
CN107129538B
(zh)
*
|
2010-04-27 |
2021-07-16 |
西兰制药公司 |
Glp-1受体激动剂和胃泌素的肽缀合物及其用途
|
|
ES2584381T3
(es)
|
2010-05-05 |
2016-09-27 |
Prolynx Llc |
Liberación controlada de compuestos activos desde conjugados macromoleculares
|
|
EP2600897A2
(en)
|
2010-08-06 |
2013-06-12 |
The Regents of the University of Colorado, A Body Corporate |
Methods and compositions for the inhibition of fructokinase
|
|
CA3065178C
(en)
|
2010-12-13 |
2022-02-01 |
Quiapeg Pharmaceuticals Ab |
Functionalized polymers
|
|
CN103796657B
(zh)
|
2011-07-19 |
2017-07-11 |
波涛生命科学有限公司 |
合成官能化核酸的方法
|
|
CA2843506C
(en)
|
2011-08-12 |
2020-05-12 |
Ascendis Pharma A/S |
Carrier-linked prodrugs having reversible carboxylic ester linkages
|
|
CN102321170B
(zh)
*
|
2011-09-14 |
2013-11-13 |
深圳翰宇药业股份有限公司 |
利拉鲁肽变构体及其缀合物
|
|
AU2013276219B2
(en)
|
2012-06-12 |
2018-03-08 |
Quiapeg Pharmaceuticals Ab |
Conjugates of biologically active molecules to functionalized polymers
|
|
WO2014061277A1
(ja)
|
2012-10-19 |
2014-04-24 |
第一三共株式会社 |
親水性構造を含むリンカーで結合させた抗体－薬物コンジュゲート
|
|
KR102442906B1
(ko)
*
|
2013-12-19 |
2022-09-14 |
씨젠 인크. |
표적화된-약물 컨쥬게이트와 함께 사용되는 메틸렌 카바메이트 링커
|
|
AR100639A1
(es)
*
|
2014-05-29 |
2016-10-19 |
Hanmi Pharm Ind Co Ltd |
Composición para tratar diabetes que comprende conjugados de análogos de insulina de acción prolongada y conjugados de péptidos insulinotrópicos de acción prolongada
|
|
AU2015277100A1
(en)
*
|
2014-06-20 |
2017-02-02 |
Abgenomics International Inc. |
HER2 antibody-drug conjugates
|
|
JP6369721B2
(ja)
|
2014-07-04 |
2018-08-08 |
国立大学法人 東京大学 |
リゾホスファチジルセリン誘導体
|
|
CN104725628B
(zh)
|
2014-10-01 |
2018-04-17 |
厦门赛诺邦格生物科技股份有限公司 |
一种含可降解基团的单一官能化支化聚乙二醇、制备方法及其生物相关物质
|
|
EP3242689A1
(en)
|
2015-01-09 |
2017-11-15 |
Ascendis Pharma Growth Disorders A/S |
Cnp prodrugs
|
|
CA2979895A1
(en)
|
2015-03-18 |
2016-09-22 |
Immunobiochem Corporation |
Conjugates for the treatment of cancer targeted at intracellular tumor-associated antigens
|
|
CN107921030B
(zh)
|
2015-08-14 |
2024-07-02 |
荣昌生物制药(烟台)股份有限公司 |
抗体-药物偶联物的共价连接子及其制备方法与应用
|
|
CA3007976C
(en)
|
2016-01-08 |
2023-09-26 |
Ascendis Pharma Growth Disorders A/S |
Cnp prodrugs with large carrier moieties
|
|
DK3400019T3
(da)
|
2016-01-08 |
2022-10-24 |
Ascendis Pharma Growth Disorders As |
CNP-prodrugs med bærerbinding ved ringenheden
|
|
GB201607827D0
(en)
|
2016-05-04 |
2016-06-15 |
Bicycle Therapeutics Ltd |
Bicyclic peptide-toxin conjugates specific for MT1-MMP
|
|
US10624968B2
(en)
|
2017-01-06 |
2020-04-21 |
Bicyclerd Limited |
Compounds for treating cancer
|
|
KR20190125310A
(ko)
|
2017-03-10 |
2019-11-06 |
퀴아펙 파마슈티칼스 에이비 |
방출가능한 접합체
|
|
BR102017004833A2
(pt)
*
|
2017-03-10 |
2018-10-30 |
Leite Miguel |
produto bactericida/germicida/fungicida/esporocida extraído dos ácidos graxos a ser administrado via oral em animais de criação monogástricos e/ou ruminantes e método de obtenção
|
|
KR20220127380A
(ko)
|
2018-03-09 |
2022-09-19 |
퀴아펙 파마슈티칼스 에이비 |
방출가능한 항체 접합체
|
|
CA3112473A1
(en)
|
2018-09-12 |
2020-03-19 |
Quiapeg Pharmaceuticals Ab |
Releasable glp-1 conjugates
|